Record-setting health care fraud takedowns and lab-centered prosecutions have reset the compliance baseline, forcing diagnostics leaders to prove that every dollar paid and every test billed can withstand statutory, clinical, and coding scrutiny. Momentum from the Department of Justice’s 2025
A device can clear the FDA and still spend years in limbo before Medicare agrees to pay for it, a gap that has drained momentum from breakthrough technologies and stranded value for patients, providers, and investors alike. The Regulatory Alignment for Predictable and Immediate Device (RAPID)
Introduction Phone lines that once confirmed Medicare approvals in days now relay weekslong holds as an AI gatekeeper reroutes care through a new federal experiment in Washington. The WISeR model—short for Wasteful and Inappropriate Service Reduction—was designed to slow unnecessary spending, yet
The federal government’s decision to prioritize clinical results over administrative responsiveness marks a seismic departure from decades of established Medicare oversight and will permanently alter the financial trajectory of private insurance markets. What happens when the federal government
Streamlining the Journey from Innovation to Patient Care The traditional five-year waiting period for Medicare beneficiaries to access breakthrough medical technologies is finally being dismantled by a structural synchronization that aligns federal safety approval with reimbursement reality. The
James Maitland stands at the forefront of the technological revolution in medicine, specializing in how robotics and IoT can be harmonized with human care. With a career built on the belief that technology should serve humanity rather than distract from it, Maitland offers a unique perspective on
